CRL · 8-K · 20260805PR000115

Liquidity and Debt Position

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · 2026-08-05 · Importance 71 · Surprise 48 · From source text

Cash and cash equivalents were $192.0 million at June 27, 2026, down from $213.8 million at December 27, 2025. Long-term debt, net of finance leases, increased to $2.620 billion from $2.136 billion over the same period, a $483.6 million increase. Six-month proceeds from long-term debt and the revolving credit facility were $1.265 billion, while repayments were $745.9 million. Ending cash, cash equivalents, and restricted cash totaled $240.6 million after six-month operating cash flow of $220.8 million and net financing cash inflow of $183.1 million.

Key facts

Impact estimates

metricdirectionstageexpectedbasis
cashpositiverealized+16.8%Proceeds from long-term debt and revolving credit facility: $1,265,258 thousand in six months ended June 27, 2026; payments on long-term…
liabilitynegativerealized-16.8%Proceeds from long-term debt and revolving credit facility: $1,265,258 thousand in six months ended June 27, 2026; payments on long-term…
cashnegativerealized-9.9%Proceeds from long-term debt and revolving credit facility: $1,265,258 thousand in six months ended June 27, 2026; payments on long-term…
liabilitypositiverealized+9.9%Proceeds from long-term debt and revolving credit facility: $1,265,258 thousand in six months ended June 27, 2026; payments on long-term…
assetsnegativerealized-1.1%Intangible assets, net as of June 27, 2026: $253,174 thousand (down from $339,995 as of December 27, 2025).
assetspositiverealized+0.6%Inventories as of June 27, 2026: $346,260 thousand (up from $299,103 thousand at December 27, 2025).
liabilitynegativerealizedLong-term debt, net and finance leases as of June 27, 2026: $2,619,985 thousand.